uMotif, an eClinical platform provider powering patient-centric research, has joined up with researchers at The University of Manchester to investigate the real-world usability of its digital body mapping tool in a feasibility study in people living with musculoskeletal conditions. The University’s Manchester Digital Pain Manikin (MDPM) app has been developed by uMotif and utilizes its body mapping technology, making it faster and easier for patients to accurately report the location of their pain to study teams via their smartphone. Findings from the study are shedding light on how a digital body map can improve pain reporting, which in turn can enhance the support and care of individuals who experience long-term pain.
Data collection for The University of Manchester’s feasibility study is currently underway, with nearly 100 patients taking part through a decentralized and bring-your-own-device (BYOD) research design. A series of workshops have also taken place to gather user feedback and better understand the influence of ethnicity and cultural background on pain reporting behavior. Future studies will focus on further evaluating the tool’s validity as a research-quality pain measurement instrument. It is anticipated that this opportunity will contribute to the technology becoming a new standard for how long-term pain can be measured, analyzed, and reported.
uMotif plans to expand its concepts in body mapping technology to other therapeutic areas, such as dermatology, in the future.
uMotif Collaborates with The University of Manchester on Body Mapping Tool
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.